Back to Search
MELISSA HENSLEY, M.D.
M.D.
Student in an Organized Health Care Education/Training Program
NPI: 1982963849Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.
PMID 19135708·Gynecol Oncol·2009
3-trial
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.
PMID 19018081·J Clin Oncol·2009
8-other
A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer.
PMID 18829514·Clin Cancer Res·2008
3-trial
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.
PMID 18534250·Gynecol Oncol·2008
3-trial
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.
PMID 18394689·Gynecol Oncol·2008
3-trial
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.
PMID 17364235·Invest New Drugs·2007
3-trial
Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: pathologic complete response and longitudinal assessment of impact on cognitive functioning.
PMID 16490239·Gynecol Oncol·2006
3-trial
Economic outcomes of breast cancer survivorship: CALGB study 79804.
PMID 15868443·Breast Cancer Res Treat·2005
8-other
Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.
PMID 12798709·Gynecol Oncol·2003
8-other
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.
PMID 12065559·J Clin Oncol·2002
3-trial
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.
PMID 10715301·J Clin Oncol·2000
8-other
No improvement in lung cancer care: the management of lung cancer in 1996 and 2002 in New South Wales.
PMID 19220546·Intern Med J·2009
4-observational
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
PMID 19255317·J Clin Oncol·2009
8-other
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
PMID 19451436·J Clin Oncol·2009
3-trial
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
PMID 19666190·Gynecol Oncol·2009
8-other
Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541.
PMID 19170232·Cancer·2009
8-other
A comparison of single-photon emission CT lung scintigraphy and CT pulmonary angiography for the diagnosis of pulmonary embolism.
PMID 19525358·Chest·2009
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE
ROCHESTER, NY 14642 - Phone
- (585) 275-2723
Quick Facts
- NPI
- 1982963849
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile